Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.15 | 0.5 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |